Intraspinal Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: Phase 1 Trial Outcomes

OBJECTIVE: The US Food and Drug Administration–approved trial, “A Phase 1, Open-Label, First-in-Human, Feasibility and Safety Study of Human Spinal Cord-Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis, Protocol Number: NS2008-1,” is complete. Our overall o...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldman, Eva L, Boulis, Nicholas M, Hur, Junguk, Johe, Karl, Rutkove, Seward B, Federici, Thais, Polak, Meraida, Bordeau, Jane, Sakowski, Stacey A, Glass, Jonathan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005820/
https://www.ncbi.nlm.nih.gov/pubmed/24510776
http://dx.doi.org/10.1002/ana.24113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005820/
https://www.ncbi.nlm.nih.gov/pubmed/24510776
http://dx.doi.org/10.1002/ana.24113

Ejemplares similares